Reportedly, antiapoptotic Bcl-2 family proteins suppress apoptosis by binding to and inhibiting members of the CED-4 family of caspase activators. To explore this question, we used embryonic stem (ES) cells in which one (−/+) or both (−/−) copies of the gene encoding apoptotic protease activating factor 1 (Apaf-1), a CED-4 homologue, were disrupted by homologous recombination. Stable clones of heterozygous (−/+) and homozygous (−/−) Apaf-1 knockout ES cells that overexpressed Bcl-2 were generated. Withdrawal of serum growth factors or stimulation of heterozygous ES cells with staurosporine (STS), ultraviolet (UV)B irradiation, etoposide (VP16), or cisplatin induced apoptosis followed by cell death (determined by failure to exclude propidium iodide dye). These cell death stimuli also induced activation of several types of caspases and loss of mitochondrial membrane potential (ΔΨ) in heterozygous (+/−) Apaf-1 knockout ES cells. In addition, overexpression of Bcl-2 protected against these events in Apaf-1–expressing ES cells. In contrast, STS, UVB, and VP16 induced little or no caspase activation and apoptosis in homozygous (−/−) Apaf-1 knockout ES cells. Nevertheless, Apaf-1–deficient ES cells subjected to these cell death stimuli or deprived of growth factors did eventually die through a nonapoptotic mechanism associated with loss of ΔΨ. Moreover, Bcl-2 overprotection preserved ΔΨ, reduced the percentage of Apaf-1−/− ES cells undergoing cell death, and increased clonigenic survival. The extent of Bcl-2–mediated cytoprotection was not significantly different for heterozygous (−/+) versus homozygous (−/−) Apaf-1 knockout cells. Furthermore, although Bcl-2 could be readily coimmunoprecipitated with Bax, associations with Apaf-1 were undetectable under conditions where Apaf-1 interactions with procaspase-9 were observed. We conclude that Bcl-2 has cytoprotective functions independent of Apaf-1, preserving mitochondrial function through a caspase-independent mechanism.
Skip Nav Destination
Article navigation
15 May 2000
Article|
May 15 2000
Apoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2
Misako Haraguchi,
Misako Haraguchi
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Seiji Torii,
Seiji Torii
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Shu-ichi Matsuzawa,
Shu-ichi Matsuzawa
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Zhihua Xie,
Zhihua Xie
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Shinichi Kitada,
Shinichi Kitada
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Stanislaw Krajewski,
Stanislaw Krajewski
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Hiroki Yoshida,
Hiroki Yoshida
bDepartment of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
Tak W. Mak,
Tak W. Mak
bDepartment of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2C1
Search for other works by this author on:
John C. Reed
John C. Reed
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Search for other works by this author on:
Misako Haraguchi
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Seiji Torii
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Shu-ichi Matsuzawa
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Zhihua Xie
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Shinichi Kitada
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Stanislaw Krajewski
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Hiroki Yoshida
bDepartment of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2C1
Tak W. Mak
bDepartment of Cellular and Molecular Biology, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2C1
John C. Reed
aBurnham Institute Program on Apoptosis and Cell Death Regulation, La Jolla, California 92037
Abbreviations used in this paper: Apaf-1, apoptotic protease activating factor 1; CP, cisplatin; ΔΨ, mitochondrial transmembrane potential; ES, embryonic stem; PI, propidium iodide; STS, staurosporine.
Received:
December 16 1999
Revision Requested:
March 02 2000
Accepted:
March 09 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (10): 1709–1720.
Article history
Received:
December 16 1999
Revision Requested:
March 02 2000
Accepted:
March 09 2000
Citation
Misako Haraguchi, Seiji Torii, Shu-ichi Matsuzawa, Zhihua Xie, Shinichi Kitada, Stanislaw Krajewski, Hiroki Yoshida, Tak W. Mak, John C. Reed; Apoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2. J Exp Med 15 May 2000; 191 (10): 1709–1720. doi: https://doi.org/10.1084/jem.191.10.1709
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement